Prostate News Archive
02-Jan-2009
Why prostate hormone therapy temporary (UPI)
BALTIMORE, Dec. 31 (UPI) -- Hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, but U.S. researchers suggest why. Retired U of M prostate cancer pioneer dies (Minneapolis - St. Paul Business Journal)
Donald Gleason, a retired University of Minnesota Medical School professor who developed a system for rating prostate cancer tumors, died of heart failure on Dec. 28. He was 88. FDA Approves First Prostate Cancer Drug in Years: Degarelix for Men with Advanced Cases (Senior Journal)
Company waiting for a trade name before beginning marketing in U.S. Dec. 31, 2008 ? An injectable drug, degarelix, became the first new drug approved in several years by the Food and Drug Administration for the treatment of prostate cancer. Hormone deprivation cannot cure prostate cancer (New Kerala)
Washington, Jan 1 : Hormone deprivation therapy in prostate cancer only provides temporary relief, with tumours usually regaining their hold within a couple of years. Gay And Bisexual African-American Men Have The Lowest Use Of Prostate Testing (Medical News Today)
Gay and bisexual black men are less likely to be tested for prostate cancer than men of any other racial and ethnic backgrounds regardless of their sexual orientation, according to a recent study by a researcher at Charles Drew University of Medicine and Science. In his study, published in the December issue of Medical Care, Kevin C.
Back to Prostate News Archive
